BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 21158723)

  • 1. Magnetic iron oxide nanoparticles for tumor-targeted therapy.
    Chen B; Wu W; Wang X
    Curr Cancer Drug Targets; 2011 Feb; 11(2):184-9. PubMed ID: 21158723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application and advancement of magnetic iron-oxide nanoparticles in tumor-targeted therapy].
    Chen Y; Chen BA
    Chin J Cancer; 2010 Jan; 29(1):125-8. PubMed ID: 20038325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications.
    Gupta AK; Naregalkar RR; Vaidya VD; Gupta M
    Nanomedicine (Lond); 2007 Feb; 2(1):23-39. PubMed ID: 17716188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
    Zhu L; Zhou Z; Mao H; Yang L
    Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles for cancer therapy using magnetic forces.
    Tietze R; Lyer S; Dürr S; Alexiou C
    Nanomedicine (Lond); 2012 Mar; 7(3):447-57. PubMed ID: 22385201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
    Gupta AK; Gupta M
    Biomaterials; 2005 Jun; 26(18):3995-4021. PubMed ID: 15626447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic nanoformulations for prostate cancer.
    Chowdhury P; Roberts AM; Khan S; Hafeez BB; Chauhan SC; Jaggi M; Yallapu MM
    Drug Discov Today; 2017 Aug; 22(8):1233-1241. PubMed ID: 28526660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nanomedicine : Magnetic nanoparticles for drug delivery and hyperthermia - new chances for cancer therapy].
    Alexiou C; Tietze R; Schreiber E; Lyer S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):839-45. PubMed ID: 20700784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model.
    Rego GNA; Mamani JB; Souza TKF; Nucci MP; Silva HRD; Gamarra LF
    Einstein (Sao Paulo); 2019 Aug; 17(4):eAO4786. PubMed ID: 31390427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery.
    Kossatz S; Grandke J; Couleaud P; Latorre A; Aires A; Crosbie-Staunton K; Ludwig R; Dähring H; Ettelt V; Lazaro-Carrillo A; Calero M; Sader M; Courty J; Volkov Y; Prina-Mello A; Villanueva A; Somoza Á; Cortajarena AL; Miranda R; Hilger I
    Breast Cancer Res; 2015 May; 17(1):66. PubMed ID: 25968050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time infrared thermography detection of magnetic nanoparticle hyperthermia in a murine model under a non-uniform field configuration.
    Rodrigues HF; Mello FM; Branquinho LC; Zufelato N; Silveira-Lacerda EP; Bakuzis AF
    Int J Hyperthermia; 2013 Dec; 29(8):752-67. PubMed ID: 24138472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermoresponsive core-shell magnetic nanoparticles for combined modalities of cancer therapy.
    Purushotham S; Chang PE; Rumpel H; Kee IH; Ng RT; Chow PK; Tan CK; Ramanujan RV
    Nanotechnology; 2009 Jul; 20(30):305101. PubMed ID: 19581698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic Nanoparticles: Properties, Synthesis and Biomedical Applications.
    Khan S; Rizvi SM; Ahmad V; Baig MH; Kamal MA; Ahmad S; Rai M; Zafar Iqbal AN; Mushtaq G; Khan MS
    Curr Drug Metab; 2015; 16(8):685-704. PubMed ID: 26264204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization and Design of Magnetic Ferrite Nanoparticles with Uniform Tumor Distribution for Highly Sensitive MRI/MPI Performance and Improved Magnetic Hyperthermia Therapy.
    Du Y; Liu X; Liang Q; Liang XJ; Tian J
    Nano Lett; 2019 Jun; 19(6):3618-3626. PubMed ID: 31074627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered Inorganic/Organic-Core/Shell Magnetic FexOy Nanoparticles with Oleic Acid and/or Oleylamine As Capping Agents.
    Harris RA; van der Walt H; Shumbula PM
    Curr Pharm Des; 2015; 21(37):5369-88. PubMed ID: 26377658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications and potential toxicity of magnetic iron oxide nanoparticles.
    Liu G; Gao J; Ai H; Chen X
    Small; 2013 May; 9(9-10):1533-45. PubMed ID: 23019129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and functionalisation of magnetic nanoparticles for hyperthermia applications.
    Grüttner C; Müller K; Teller J; Westphal F
    Int J Hyperthermia; 2013 Dec; 29(8):777-89. PubMed ID: 24099465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics.
    Vangijzegem T; Stanicki D; Laurent S
    Expert Opin Drug Deliv; 2019 Jan; 16(1):69-78. PubMed ID: 30496697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic iron oxide nanoparticles as drug carriers: clinical relevance.
    El-Boubbou K
    Nanomedicine (Lond); 2018 Apr; 13(8):953-971. PubMed ID: 29376469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron oxide nanoparticles - In vivo/in vitro biomedical applications and in silico studies.
    Nedyalkova M; Donkova B; Romanova J; Tzvetkov G; Madurga S; Simeonov V
    Adv Colloid Interface Sci; 2017 Nov; 249():192-212. PubMed ID: 28499604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.